Evidence map›Paper›PMID 31515523›Full record

ArticleJournal of human genetics2019

SPTAN1 variants as a potential cause for autosomal recessive hereditary spastic paraplegia.

Etienne Leveille, Mehrdad A Estiar, Lynne Krohn, Dan Spiegelman, Alexandre Dionne-Laporte, Nicolas Dupré, Jean François Trempe, Guy A Rouleau, Ziv Gan-Or

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Expanding SPTAN1 monoallelic variant associated disorders: From epileptic encephalopathy to pure spastic paraplegia and ataxia.Genetics in medicine : official journal of the American College of Medical Genetics · 2023
    Article
  5. Article
  6. De Novo and Dominantly Inherited SPTAN1 Mutations Cause Spastic Paraplegia and Cerebellar Ataxia.Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Etienne LeveilleFaculty of Medicine, McGill University, Montréal, QC, Canada.
Mehrdad A EstiarDepartment of Human Genetics, McGill University, Montréal, QC, Canada.
Lynne KrohnDepartment of Human Genetics, McGill University, Montréal, QC, Canada.
Dan SpiegelmanMontreal Neurological Institute and Hospital, McGill University, Montréal, QC, Canada.
Alexandre Dionne-LaporteMontreal Neurological Institute and Hospital, McGill University, Montréal, QC, Canada.
Nicolas DupréDivision of Neurosciences, CHU de Québec, Université Laval, Québec City, QC, Canada.
Jean François TrempeDepartment of Pharmacology & Therapeutics, McGill University, Montréal, QC, Canada.
Guy A RouleauDepartment of Human Genetics, McGill University, Montréal, QC, Canada. guy.rouleau@mcgill.ca.
Ziv Gan-OrDepartment of Human Genetics, McGill University, Montréal, QC, Canada. ziv.gan-or@mcgill.ca.
McGill University · CAMontreal Neurological Institute and Hospital · CAUniversité Laval · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

More than 80 known or suspected genes/loci have been reported to be involved in hereditary spastic paraplegia (HSP). Genetic and clinical overlap have been reported between HSP and other neurological condition, yet about 50% of HSP patients remain genetically undiagnosed. To identify novel genes involved in HSP, we performed a genetic analysis of 383 HSP patients from 289 families with HSP. Two patients with biallelic SPTAN1 variants were identified; one carried the c.2572G>T p.(Ala858Ser) and c.4283C>G p.(Ala1428Gly) variants, and the second also carried the c.2572G>T p.(Ala858Ser) variant, and an additional variant, c.6990G>C p.(Met2330Ile). In silico predictive and structural analyses suggested that these variants are likely to be deleterious. SPTAN1 was highly intolerant for functional variants (in the top 0.31% of intolerant genes) with much lower observed vs. expected number of loss-of-function variants (8 vs. 142.7, p < 5 × 10

Indexed as

AnimalsAxonsCarrier ProteinsComputer SimulationFemaleHeterozygoteHumansMaleMiceMicrofilament ProteinsModels, AnimalMutationNerve DegenerationPhenotypeProtein ConformationSpastic Paraplegia, HereditaryCarrier ProteinsMicrofilament ProteinsSpectrin

Identifiers

PMID31515523
OpenAlexW2972587176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.